Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-10-09

Clinical Trial Update: Use of Ticagrelor in Korean ACS Patients: The BRILIANT KOREA Registry

View source ↗

Summary

An update on the BRILIANT KOREA registry studying ticagrelor use in Korean patients with acute coronary syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BRILINTA (ticagrelor)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Acute Coronary Syndrome | Status: UNKNOWN